+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Etanercept"

TNF Alpha Inhibitors Global Market Report 2024 - Product Thumbnail Image

TNF Alpha Inhibitors Global Market Report 2024

  • Report
  • February 2024
  • 250 Pages
  • Global
From
From
From
Ankylosing Spondylitis - Pipeline Insight, 2024 - Product Thumbnail Image

Ankylosing Spondylitis - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 80 Pages
  • Global
From
Graft versus host disease - Pipeline Insight, 2024 - Product Thumbnail Image

Graft versus host disease - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 220 Pages
  • Global
From
From
From
US Axial Spondyloarthritis Market outlook to 2028 - Product Thumbnail Image

US Axial Spondyloarthritis Market outlook to 2028

  • Report
  • October 2023
  • 85 Pages
  • United States
From
From
From
Innovations in Biopharmaceutical Treatments - Product Thumbnail Image

Innovations in Biopharmaceutical Treatments

  • Report
  • July 2018
  • 15 Pages
  • Global
From
From
From
From
ENBREL Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

ENBREL Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • January 2023
  • 30 Pages
  • Global
From
From
Etanercept- Biosimilar Insight, 2022 - Product Thumbnail Image

Etanercept- Biosimilar Insight, 2022

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Loading Indicator

Etanercept is a biologic drug used to treat immune disorders such as rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and plaque psoriasis. It is a recombinant fusion protein that works by blocking the action of tumor necrosis factor (TNF), a protein involved in inflammation. Etanercept is administered by subcutaneous injection and is available in both brand name and generic forms. Etanercept is a widely used drug in the treatment of immune disorders, and is often prescribed in combination with other medications. It is generally well tolerated, with the most common side effects being injection site reactions, headache, and upper respiratory tract infections. The etanercept market is highly competitive, with several major players. These include Amgen, Pfizer, AbbVie, and Johnson & Johnson. Other companies in the market include Biogen, Merck, and Novartis. Show Less Read more